Coloplast A/S (OTCMKTS:CLPBY) Shares Pass Below 50 Day Moving Average – Time to Sell?

Coloplast A/S (OTCMKTS:CLPBYGet Free Report) crossed below its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $10.88 and traded as low as $9.95. Coloplast A/S shares last traded at $9.95, with a volume of 203,967 shares traded.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on CLPBY. Royal Bank of Canada upgraded shares of Coloplast A/S from a “hold” rating to a “moderate buy” rating in a research report on Monday, March 3rd. Sanford C. Bernstein raised shares of Coloplast A/S from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, January 28th. Finally, UBS Group upgraded Coloplast A/S from a “strong sell” rating to a “hold” rating in a report on Wednesday, December 11th.

View Our Latest Stock Analysis on Coloplast A/S

Coloplast A/S Stock Performance

The company has a debt-to-equity ratio of 0.92, a quick ratio of 0.66 and a current ratio of 1.02. The firm’s 50 day moving average is $10.88 and its 200 day moving average is $11.77.

Coloplast A/S (OTCMKTS:CLPBYGet Free Report) last posted its quarterly earnings results on Tuesday, February 4th. The company reported $0.07 earnings per share for the quarter, missing the consensus estimate of $0.08 by ($0.01). Coloplast A/S had a return on equity of 28.60% and a net margin of 17.81%. Research analysts anticipate that Coloplast A/S will post 0.31 EPS for the current fiscal year.

About Coloplast A/S

(Get Free Report)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments.

Featured Stories

Receive News & Ratings for Coloplast A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Coloplast A/S and related companies with MarketBeat.com's FREE daily email newsletter.